Superior AIDS-Kaposi’s Sarcoma Treatment Identified | NIH: National Institute of Allergy and Infectious Diseases

Superior AIDS-Kaposi’s Sarcoma Treatment Identified | NIH: National Institute of Allergy and Infectious Diseases

Friday, March 6, 2020

NIAID Now: Superior AIDS-Kaposi’s Sarcoma Treatment Improves Outcomes in Resource-Limited Settings

The cancer drug paclitaxel and a suppressive regimen of antiretroviral therapy (ART) is an effective treatment for AIDS-related Kaposi’s sarcoma, according to researchers who conducted a clinical trial comparing three chemotherapy regimens in combination with ART in people with advanced AIDS-Kaposi’s sarcoma in Africa and South America. The full findings, published online yesterday in The Lancet, affirmed conclusions from interim data released when the trial ended early in March 2018.